Title of article :
Predicting relapse in ductal carcinoma in situ patients: an analysis of biologic markers with long-term follow-up
Author/Authors :
Tina J. Hieken، نويسنده , , John Cheregi، نويسنده , , Miguel Farolan، نويسنده , , Joan Kim، نويسنده , , Jose M. Velasco، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2007
Pages :
3
From page :
504
To page :
506
Abstract :
Background The incidence of ductal carcinoma in situ (DCIS) of the breast is increasing. Optimal treatment remains controversial and, because of a long natural history, may not be evident for many years. We undertook this study to identify markers of disease recurrence. Methods We studied 131 pure DCIS patients with a 100-month mean follow-up. We performed a complete histologic review, immunohistochemical staining for p53 and vascular endothelial growth factor expression, and enumerated microvessel density/mm2 using factor VIII-Ab. Statistical analysis was performed by using an SAS software package (Cary, NC). Results Eleven patients (8%) developed ipsilateral recurrence at a mean of 55 months (11–137 months) after initial treatment. Three were DCIS, and 8 were invasive cancer. Recurrence was significantly predicted by p53 overexpression (in 55% of tumors that recurred versus 22% of those that did not, P = .02) but not other factors. Conclusions These data suggest that biologic factors may have an important role in predicting recurrence in DCIS patients.
Keywords :
recurrence , Angiogenic factors , Biologic markers , p53 , Long-term follow-up , Ductal carcinoma in situ of the breast
Journal title :
The American Journal of Surgery
Serial Year :
2007
Journal title :
The American Journal of Surgery
Record number :
618846
Link To Document :
بازگشت